iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionTwo Sigma Investments, Lp
ManagerJohn Overdeck, David Siegel
Latest Disclosed Ownership557,807 shares
Latest Disclosed Value $ 94,185,712
Two Sigma Investments, Lp ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Two Sigma Investments, Lp filed a 13F-HR form disclosing ownership of 557,807 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $94,185,712 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,475,007 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -62.18% during the quarter. The current value of the position is $73,100,607 USD.

Two Sigma Investments, Lp has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 557,807 -917,200 -62.18 94,186 -62.16 0.0760
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,475,007 1,409,300 2,144.82 248,937 2,524.25 0.3511
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 65,707 65,707 9,486 0.0141
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -277,807 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 277,807 43,200 18.41 35,532 14.55 0.0759
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 234,607 -49,600 -17.45 31,017 -25.04 0.0676
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 284,207 -139,200 -32.88 41,381 -28.80 0.0907
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 423,407 116,200 37.82 58,117 37.87 0.1324
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 307,207 307,207 42,155 0.0989
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -136,807 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 136,807 19,000 16.13 17,369 14.16 0.0436
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 117,807 -121,100 -50.69 15,216 -51.49 0.0435
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 238,907 182,200 321.30 31,366 372.95 0.0985
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 56,707 56,707 6,632 0.0225
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -272,501 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 272,501 -267,506 -49.54 35,507 -56.92 0.1048
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 540,007 -100,838 -15.74 82,416 -20.46 0.1761
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 640,845 219,538 52.11 103,612 50.28 0.2316
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 421,307 22,100 5.54 68,947 14.71 0.1564
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 399,207 185,100 86.45 60,105 85.31 0.1564
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 214,107 210,162 5,327.30 32,435 5,973.97 0.0931
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,945 -62,215 -94.04 534 -94.09 0.0019
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 66,160 66,160 1,577.06 9,043 1,593.45 0.0448
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -640,760 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 640,760 208,756 48.32 77,218 79.64 0.2323
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 432,004 258,155 148.49 42,984 126.63 0.1446
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 173,849 995 0.58 18,967 -1.85 0.0634
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 172,854 -43,453 -20.09 19,325 -7.35 0.0626
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 216,307 -133,304 -38.13 20,858 -51.07 0.0817
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 349,611 349,611 61.63 42,632 104.39 0.1162
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -6,000 -100.00 0 -100.00
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,000 -281,131 -97.91 640 -97.91 0.0021
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 287,131 273,131 1,950.94 30,657 556.47 0.0998
2017-11-14 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 14,000 14,000 -95.12 4,670 -84.77 0.0166
2017-05-15 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -68,891 -100.00 0 -100.00
2017-02-14 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 68,891 31,207 82.81 18,282 67.60 0.0701
2016-11-14 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 37,684 35,484 1,612.91 10,908 1,827.21 0.0395
2016-08-15 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,200 -33,904 -93.91 566 -93.99 0.0024
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 36,104 36,104 1,541.09 9,416 1,563.60 0.0449
2016-02-16 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -172,759 -100.00 0 -100.00
2015-11-16 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 172,759 143,057 481.64 52,403 378.17 0.2685
2016-02-09 2015-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 29,702 29,702 -82.81 10,959 -79.09 0.0532
2015-08-14 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 29,702 10,959
2014-08-14 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 0 -203,224 -100.00 0 -100.00
2014-05-15 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 203,224 203,224 48,052 0.2574
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-16 2022-03-31 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH Call 3,900 -22.00 595 -26.36 n/a n/a n/a
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH Call 5,000 -70.59 808 -70.96 n/a n/a n/a
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH Call 17,000 750.00 2,782 824.25 n/a n/a n/a
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH Call 2,000 -88.24 301 -89.18 n/a n/a n/a
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Call 3,000 -25.00 406 -25.78 n/a n/a n/a
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Call 4,000 -33.33 547 -15.33 n/a n/a n/a
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Call 6,000 50.00 646 18.10 n/a n/a n/a
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Call 20,000 150.00 1,990 127.95 n/a n/a n/a
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Call 8,000 -60.00 873 -56.13 n/a n/a n/a
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Call 6,000 -79.31 732 -77.02 n/a n/a n/a
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH Call 29,000 480.00 3,185 496.44 n/a n/a n/a
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Call 5,000 534 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-16 2022-03-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH Put 6,600 -26.67 1,007 -30.79 n/a n/a n/a
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH Put 9,000 -57.14 1,455 -57.67 n/a n/a n/a
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH Put 21,000 3,437 n/a n/a n/a
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Put 3,000 -78.57 406 -78.79 n/a n/a n/a
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Put 14,000 28.44 1,914 63.03 n/a n/a n/a
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Put 10,900 -22.14 1,174 -38.66 n/a n/a n/a
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Put 21,000 133.33 2,090 112.83 n/a n/a n/a
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Put 9,000 -57.14 982 -53.01 n/a n/a n/a
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Put 6,000 -80.65 732 -78.50 n/a n/a n/a
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH Put 31,000 342.86 3,404 355.69 n/a n/a n/a
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Put 7,000 747 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.